Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 438 of 6351
-
Blood clues may unmask Alzheimer's earliest inflammatory changes
Knowledge-focused Recruiting nowThis project aims to longitudinally profile plasma-derived GDEVs and plasma biomarkers of neuroinflammation across three stages of the AD continuum (Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Dementia), exploring their association with biomarkers of …
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New radioactive 'Smart Bomb' targets Hard-to-Treat lung cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[212Pb\]Pb-MP0712, in patients aged ≥18 years with Small Cell Lung Cancer and other locally advanced or metastatic DLL3 positive tumors.
Phase 1/2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New heart ablation method aims to stop AFib recurrence
Disease control Not yet recruitingThe primary objective of this study is to determine whether low-voltage areas (LVA)-guided catheter ablation combined with superior vena cava (SVC) isolation and pulmonary vein isolation (PVI), performed using the balloon-in-basket Volt™ pulsed field ablation PFA system, is super…
Sponsor: University of Luebeck • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Less may be more: smaller lung surgery tested after powerful Pre-Treatment
Disease control Recruiting nowThis study is a prospective, randomized controlled multicenter clinical trial. The study population consisted of non-small cell lung cancer(NSCLC) patients in stage IIA-IIIB (IASLC 9th edition) who received immunotherapy combined with platinum based dual drug chemotherapy before …
Sponsor: Wen-zhao ZHONG • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug duo aims to wipe out esophageal tumors before surgery
Disease control Recruiting nowThis study aims to explore the efficacy and safety of anlotinib combined with bemocizumab as neoadjuvant therapy for resectable esophageal squamous cell carcinoma, with the goal of improving the pathological complete response (pCR) rate and margin-negative resection(R0) resection…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a Brain-Zapping implant tame cluster headaches?
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate the safety and effectiveness of the Occipital Nerve Stimulation System (ONSS) in treating chronic cluster headache in adults. The study aims to answer the following questions: * What adverse events or medical complications occur…
Sponsor: Man and Science, SA • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a teacher workshop end school violence? a zambian trial aims to find out
Prevention Recruiting nowThe United Nations Conventions on the Rights of the Child UN General Assembly, 1989), outlawed violence against children worldwide. Yet, 75% of all children worldwide - experience violence while growing up (Know Violence in Childhood, 2017). In Low- and Middle-Income countries pr…
Sponsor: Tobias Hecker, PhD • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Fixing insomnia may ease strain on arteries in hypertension
Disease control Recruiting nowThis prospective, parallel-group randomised controlled trial evaluates whether cognitive-behavioural therapy for insomnia (CBT-I) improves arterial function and psychological and cognitive outcomes in hypertensive patients with poor sleep quality. Adults aged 18-70 with controlle…
Sponsor: Unidade Local de Saúde do Alto Ave, EPE • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug duo aims to wipe out lingering breast cancer cells
Disease control Recruiting nowThis phase II trial studies how well imlunestrant and abemaciclib work in treating patients with estrogen receptor positive (ER+) breast cancer who have tumor remaining in the blood following treatment (minimal residual disease). Estrogen can cause the growth of breast cancer cel…
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New monkeypox vaccine JT118 enters first human tests
Vaccine Recruiting nowThis study is a randomized, double-blind, placebo-controlled Phase I clinical trial representing the first-in-human (FIH) investigation of the Monkeypox recombinant protein vaccine JT118. The primary objectives are to evaluate the safety, tolerability, and immunogenicity of two d…
Phase 1 • Sponsor: Shanghai JunTop Biosciences Co., LTD • Aim: Vaccine
Last updated Jun 27, 2026 13:03 UTC
-
New antibody therapy targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study is being conducted to learn more about the safety, tolerability, and effectiveness of an experimental treatment for metastatic prostate cancer called AZD8359. The study is split into different modules which will look at AZD8359 delivered by different methods. The study…
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 10, 2026 08:00 UTC
-
AI could revolutionize liver cancer treatment by predicting who will benefit most
Knowledge-focused Not yet recruitingThis study aims to prospectively validate a retrospective cohort-derived AI-based multimodal model and explore tumor heterogeneity and the immune microenvironment to guide TACE combined with immunotherapy and targeted therapy in HCC.
Sponsor: Gao-jun Teng • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New hope for kids with rare seizure disorder: drug trial launches
Disease control Recruiting nowThis trial will evaluate the safety, tolerability, pharmacokinetics, and clinical activity of ABS-1230 compared with placebo in participants with KCNT1-related epilepsy
Phase 2 • Sponsor: Actio Biosciences, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New heart valve implant could offer hope for moderate aortic stenosis patients
Disease control Not yet recruitingThe primary objective of this trial is to evaluate the safety and effectiveness of Meril's Myval THV series in comparison to Guideline-Directed Medical Therapy in participants with moderate aortic stenosis. The trial includes a total of 778 participants (389:389) from approximate…
Sponsor: Meril Life Sciences Pvt. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New stroke drug TAK-755 enters human trials – could improve recovery
Disease control Recruiting nowAcute ischemic stroke (AIS) is a medical emergency that happens because of a sudden stop of blood flow to a part of the brain. This happens when a blood clot forms within the vessel (known as thrombotic occlusion) or a clot originating from somewhere else blocks a blood vessel (k…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could active video games boost brain power in kids with autism?
Symptom relief Recruiting nowThe purpose of this clinical trial is to find out whether exergame and aerobic exercise can improve sleep, movement skills, thinking abilities, and brain activity in children with autism spectrum disorder (ASD). This study aims to answer the following questions: 1. Can exergame…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
One-Time bladder treatment after kidney surgery may stop cancer comeback
Prevention Not yet recruitingThis is a prospective, single-center, single-arm phase II study evaluating whether a single postoperative intravesical instillation of disitamab vedotin (RC48) can reduce bladder recurrence after radical nephroureterectomy (RNU) in patients with HER2-positive upper tract urotheli…
Phase 2 • Sponsor: RenJi Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:34 UTC
-
New drug aims to stop chemo hair loss in its tracks
Prevention Recruiting nowClinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia
Phase 1/2 • Sponsor: Applied Biology, Inc. • Aim: Prevention
Last updated Aug 23, 2026 00:00 UTC
-
Brain implant that thinks for itself could transform Parkinson's care
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of an adaptive deep brain stimulation (aDBS) system for managing Parkinson's disease symptoms. Researchers will compare closed-loop stimulation (which automatically adjusts therapy using real-time brain signal…
Sponsor: Beijing Pins Medical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New blood test could spot cervical cancer early in High-Risk women
Diagnosis Not yet recruitingThis prospective, multicenter cohort study will recruit eligible HPV16/18-positive women from three tertiary hospitals in China. Peripheral blood samples and clinical data (cytology, HPV genotyping, colposcopy-directed biopsy) will be collected, followed by standardized mass cyto…
Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC